中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [33]
采集方式
OAI收割 [33]
内容类型
期刊论文 [33]
发表日期
2022 [33]
学科主题
筛选
浏览/检索结果:
共33条,第1-10条
帮助
限定条件
发表日期:2022
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Design of an activatable NIR-II nanoprobe for the in vivo elucidation of Alzheimer's disease-related variations in methylglyoxal concentrations
期刊论文
OAI收割
CHEMICAL SCIENCE, 2022, 卷号: 13, 期号: 42, 页码: 12511-12518
作者:
Lai, Yi
;
Dang, Yijing
;
Sun, Qian
;
Pan, Jiaxing
;
Yu, Haijun
  |  
收藏
  |  
浏览/下载:22/0
  |  
提交时间:2022/12/13
Molecular Determinants for the High-Affinity Blockade of Human Ether-a-go-go-Related Gene K+ Channel by Tolterodine
期刊论文
OAI收割
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 卷号: 80, 期号: 5, 页码: 679-689
作者:
Wang, Na
;
Yang, Yang
;
Wen, Jing
;
Fan, Xin-Rong
;
Li, Jian
  |  
收藏
  |  
浏览/下载:28/0
  |  
提交时间:2022/12/13
tolterodine
hERG channel
molecular docking
muscarinic acetylcholine receptor
tachycardia
overactive bladder
Tribulus terrestris L. extract ameliorates atherosclerosis by inhibition of vascular smooth muscle cell proliferation in ApoE(-/-) mice and A7r5 cells via suppression of Akt/MEK/ERK signaling
期刊论文
OAI收割
JOURNAL OF ETHNOPHARMACOLOGY, 2022, 卷号: 297, 页码: 15
作者:
Zhang, Jing
;
Zhao, Wai-Rong
;
Shi, Wen-Ting
;
Tan, Jun-Jie
;
Zhang, Kai-Yu
  |  
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2023/04/10
Plaque progression
Hyperlipidemia
Mitogen-activated protein kinases
Oxidized low density lipoprotein
VSMC phenotype Switching
Radical C-H Sulfonation of Arenes: Its Applications on Bioactive and DNA-Encoded Molecules
期刊论文
OAI收割
ORGANIC LETTERS, 2022, 页码: 6
作者:
Zhang, Yue
;
Xia, Shengdi
;
Shi, Wen-xia
;
Lin, Bizhen
;
Su, Xiao-can
  |  
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/13
Mass spectrometry imaging: new eyes on natural products for drug research and development
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 16
作者:
Hou, Jin-jun
;
Zhang, Zi-jia
;
Wu, Wen-yong
;
He, Qing-qing
;
Zhang, Teng-qian
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/11/11
natural product
mass spectrometry imaging
MALDI
DESI
molecular imaging
ion mobility
Ocellatuperoxides A-F, Uncommon Anti-Tumoral gamma-Pyrone Peroxides from a Photosynthetic Mollusk Placobranchus ocellatus
期刊论文
OAI收割
MARINE DRUGS, 2022, 卷号: 20, 期号: 10, 页码: 14
作者:
Li, Song-Wei
;
Wu, Qihao
;
Xu, Heng
;
Yao, Li-Gong
;
Luo, Cheng
  |  
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2022/12/13
photosynthetic mollusk
Placobranchus ocellatus
gamma-pyrone polypropionate
ocellatuperoxides
anti-tumoral activity
Surface Modifiers on Composite Particles for Direct Compaction
期刊论文
OAI收割
PHARMACEUTICS, 2022, 卷号: 14, 期号: 10, 页码: 41
作者:
Chen, Fu-Cai
;
Liu, Wen-Jun
;
Zhu, Wei-Feng
;
Yang, Ling-Yu
;
Zhang, Ji-Wen
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2022/12/13
direct compaction
particle structure
surface modifier
co-processing
Discovery of a potent and selective proteolysis targeting chimera (PROTAC) degrader of NSD3 histone methyltransferase
期刊论文
OAI收割
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 239, 页码: 18
作者:
Sun, Yaoliang
;
Zhang, Ying
;
Chen, Xiaoai
;
Yu, Aisong
;
Du, Wenhao
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/08/30
NSD3
PROTAC
Degrader
Methyltransferase
Dual-targeting prodrug nanotheranostics for NIR-II fluorescence imaging-guided photo-immunotherapy of glioblastoma
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3486-3497
作者:
Li, Fenglin
;
Lai, Yi
;
Ye, Jiayi
;
Saeed, Madiha
;
Dang, Yijing
  |  
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/12/13
Glioblastoma
Dual targeting
Photothermal therapy
NIR-II fluorescence imaging
Precise immunotherapy
Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3726-3738
作者:
Zheng, Chao
;
Zhang, Wen
;
Wang, Jinming
;
Zhai, Yihui
;
Xiong, Fengqin
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2022/12/13
KEY WORDS High-density lipoprotein
Immunotherapy
Combination therapy
Metastasis
Triple-negative breast cancer
Lenvatinib
Vadimezan
Immune checkpoint blockade